Trading window shall remain closed with effect from 09th June, 2026 (5:00 P. M.), i. e. from the date of Board Meeting intimation dated 09th June, 2026 until the expiry of 48 hours after ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aptus Pharma Limited has informed the BSE that its Board of Directors will meet on Friday, June 12, 2026, to discuss raising funds. The proposals on the table include issuing equity shares or other eligible securities through a Preferential Allotment to select investors, and taking on new borrowings from banks, financial institutions, or other lenders. The Board will also consider authorizing the Managing Director to identify prospective investors and lenders and negotiate terms. In line with insider trading rules, the trading window for company insiders (designated persons and their immediate relatives) has been closed from June 9, 2026 (5:00 PM) and will remain shut for 48 hours after the Board meeting outcome is announced. The company has clarified that this is only an exploratory stage discussion — actual issue size, price, and allottees will be decided later.
This is a preliminary signal that the company may dilute equity or take on debt soon. If a preferential allotment goes through, existing shareholders could face share dilution. Short-term, the stock may see some volatility or speculative interest ahead of the June 12 board meeting outcome.